CAR T cells for solid tumors: armed and ready to go?

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Chimeric antigen receptor (CAR) T-cell therapy shows promise but faces challenges in solid tumors.
• Solid tumors present unique biological barriers that impede CAR T-cell function and therapeutic efficacy.

Purpose of the Study:

• To review the barriers encountered by CAR T cells in solid tumors.
• To explore intrinsic and extrinsic modification strategies to enhance CAR T-cell therapy for solid tumors.

Main Methods:

• Literature review of current research on CAR T-cell therapy in solid tumors.
• Analysis of tumor microenvironment factors impacting CAR T-cell activity.
• Evaluation of genetic and non-genetic CAR T-cell engineering approaches.

Main Results:

• CAR T cells must overcome challenges including antigen specificity, tumor penetration, and immunosuppression within the tumor microenvironment.
• Intrinsic modifications can enhance CAR T-cell persistence and function.
• Extrinsic modifications can alter the tumor microenvironment to be more permissive to CAR T-cell activity.

Conclusions:

• Solid tumors pose multifaceted challenges to CAR T-cell therapy.
• Strategic modifications of CAR T cells and their microenvironment are essential for successful solid tumor treatment.
• Further research into optimizing CAR T-cell engineering holds significant therapeutic potential.